|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 93 of 350 found articles
| Title: |
P-222: A prospective phase 2 study to assess minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for newly diagnosed transplant eligible multiple myeloma patients |
| Author: |
Silvennoinen, Raija Waage, Anders Peceliunas, Valdas Schjesvold, Fredrik Anttila, Pekka Uttervall, Katarina Säily, Marjaana Putkonen, Mervi Carlson, Kristina Haukas, Einar Sankelo, Marja Partanen, Anu Szatkowski, Damian Hansson, Markus Marttila, Anu Svensson, Ronald Axelsson, Per Lauri, Birgitta Mikkola, Maija Karlsson, Conny Abelsson, Johanna Ahlstrand, Erik Sikiö, Anu Nahi, Hareth |
| Appeared in: |
Clinical lymphoma myeloma and leukemia |
| Paging: | Volume 22 () nr. S pages S157 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
Elsevier Inc. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 93 of 350 found articles
| << previous | next >> |